DEFINITY® (Perflutren Lipid Microsphere) Diagnostic Ultrasound …
Explore DEFINITY® for high-resolution ultrasound imaging in suboptimal echocardiograms, designed to enhance clinical insights and improve patient management.
Instructions For Proper Use of DEFINITY® Including Dosing and ...
Learn proper activation, understand flexible dosing, and how to administer DEFINITY®.
Safety Profile of DEFINITY® for Medical Imaging
Information and data on DEFINITY®'s safety profile across broad patient populations and multiple care settings.
DEFINITY® Ordering and Reimbursement Information
Find out how to order DEFINITY®, VIALMIX®, and PINSYNC®, and access information on return and Medicare reimbursement policies.
DEFINITY (perflutren lipid microsphere) injectable suspension, for intravenous use Initial U.S. Approval: 2001 WARNING: SERIOUS CARDIOPULMONARY REACTIONS Serious cardiopulmonary …
Demonstrating the Efficacy of DEFINITY® in Clinical Settings
Review clinical data showing how DEFINITY® improves diagnostic accuracy and patient outcomes in echocardiography.
Enhancing Ultrasound Image Quality with DEFINITY®
Discover how DEFINITY® optimizes ultrasound images with detailed guidelines on system settings for superior diagnostic outcomes.
DEFINITY® Educational Programs and Resources for Healthcare …
Access webinars, programs, and educational materials designed to enhance the use of DEFINITY® in clinical practice.
Contact Support for DEFINITY® Users
Get in touch with Lantheus or Definity customer support for assistance on inquiries or issues related to the use of DEFINITY®.
DEFINITY RT is intended for administration only after activation in the VIALMIX RFID apparatus. Before injection, this product must be activated, diluted, and prepared according to the instructions outlined …